$BANT
Bantec, Inc. Stock $bant

$bant Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000121390024022084 Filed on March 13, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2022 Q4
Revenue	$771.7K	$955.7K	$606.2K
YoY Change	23.84%	57.67%	50.74%
Cost Of Revenue	$675.0K	$808.2K	$511.2K
YoY Change	31.08%	58.09%	66.36%
Gross Profit	$96.65K	$147.5K	$94.95K
YoY Change	-10.65%	55.39%	0.14%
Gross Profit Margin	12.53%	15.44%	15.66%
Selling, General & Admin	$510.6K	$454.8K	$514.3K
YoY Change	6.05%	-11.57%	-21.4%
% of Gross Profit	528.29%	308.23%	541.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$250.00	$220.00
YoY Change
% of Gross Profit	0.26%	0.15%
Operating Expenses	$510.6K	$454.8K	$514.3K
YoY Change	6.05%	-11.57%	-21.4%
Operating Profit	-$413.9K	-$307.2K	-$419.3K
YoY Change	10.89%	-26.73%	-25.05%
Interest Expense	-$532.3K	-$169.1K	-$362.3K
YoY Change	16.38%	-53.32%	23.46%
% of Operating Profit
Other Income/Expense, Net	$5.000K	-$169.1K	-$362.3K
YoY Change	-101.09%	-53.32%	23.46%
Pretax Income	-$946.2K	-$476.4K	-$781.7K
YoY Change	13.91%	-39.06%	-8.36%
Income Tax
% Of Pretax Income
Net Earnings	-$946.2K	-$476.4K	-$781.7K
YoY Change	13.91%	-39.06%	-8.36%
Net Earnings / Revenue	-122.62%	-49.84%	-128.95%
Basic Earnings Per Share	-$0.10	-$0.05	$0.00
Diluted Earnings Per Share	-$0.10	-$0.05	$0.00
COMMON SHARES
Basic Shares Outstanding	10.28M shares	9.543M shares	5.864B shares
Diluted Shares Outstanding	10.26M shares	9.543M shares	5.327B shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$44.97K	$101.2K	$94.94K
YoY Change	343.05%	6.63%	-87.86%
Cash & Equivalents	$44.97K	$101.2K	$94.94K
Short-Term Investments
Other Short-Term Assets	$20.00K	$0.00	$4.660K
YoY Change	329.18%	-100.0%	-34.55%
Inventory	$234.6K	$132.8K	$92.37K
Prepaid Expenses
Receivables	$196.3K	$291.4K	$116.5K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$495.8K	$525.4K	$308.5K
YoY Change	24.58%	70.3%	-68.43%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.627K	$2.885K	$1.461K
YoY Change	79.81%	97.47%	-98.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$109.0K	$119.9K	$22.01K
YoY Change	1124.15%	444.69%	-90.77%
TOTAL ASSETS
Total Short-Term Assets	$495.8K	$525.4K	$308.5K
Total Long-Term Assets	$109.0K	$119.9K	$22.01K
Total Assets	$604.8K	$645.3K	$330.5K
YoY Change	48.64%	95.23%	-72.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.535M	$2.337M	$2.611M
YoY Change	-6.69%	-10.49%	-3.54%
Accrued Expenses	$4.083M	$3.834M	$5.355M
YoY Change	-30.58%	-28.41%	15.94%
Deferred Revenue
YoY Change
Short-Term Debt	$1.800M	$1.467M	$834.0K
YoY Change	-78.59%	75.85%	-3.47%
Long-Term Debt Due	$898.5K	$923.8K	$7.715M
YoY Change	176.96%	-88.03%	0.04%
Total Short-Term Liabilities	$9.837M	$8.948M	$16.68M
YoY Change	-43.66%	-46.34%	3.78%
LONG-TERM LIABILITIES
Long-Term Debt	$8.938M	$8.894M	$126.7K
YoY Change	5858.59%	6917.67%	-58.1%
Other Long-Term Liabilities	$62.38K	$74.31K
YoY Change
Total Long-Term Liabilities	$9.000M	$8.969M	$126.7K
YoY Change	5900.17%	6976.3%	-60.92%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.837M	$8.948M	$16.68M
Total Long-Term Liabilities	$9.000M	$8.969M	$126.7K
Total Liabilities	$18.84M	$17.92M	$16.80M
YoY Change	6.98%	6.63%	2.5%
SHAREHOLDERS EQUITY
Retained Earnings	-$39.28M	-$38.33M	-$36.41M
YoY Change	5.47%	5.27%
Common Stock	$1.073K	$1.023K	$586.4K
YoY Change	-99.85%	-99.83%
Preferred Stock	$45.95K	$22.70K
YoY Change	-40.08%
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$18.74M	-$17.75M	-$17.20M
YoY Change
Total Liabilities & Shareholders Equity	$604.8K	$645.3K	$330.5K
YoY Change	48.64%	95.23%	-72.82%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2022 Q4
OPERATING ACTIVITIES
Net Income	-$946.2K	-$476.4K	-$781.7K
YoY Change	13.91%	-39.06%	-8.36%
Depreciation, Depletion And Amortization	$250.00	$220.00
YoY Change
Cash From Operating Activities	-$29.24K	-$28.14K	-$133.5K
YoY Change	-84.38%	-78.93%	-61.81%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$1.558K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$1.558K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-27.02K	$95.48K	$42.06K
YoY Change	-126.38%	127.04%	-71.07%
NET CHANGE
Cash From Operating Activities	-29.24K	-$28.14K	-$133.5K
Cash From Investing Activities	0.000	-$1.558K
Cash From Financing Activities	-27.02K	$95.48K	$42.06K
Net Change In Cash	-56.26K	$65.79K	-$91.45K
YoY Change	-33.65%	-171.94%	-55.22%
FREE CASH FLOW
Cash From Operating Activities	-$29.24K	-$28.14K	-$133.5K
Capital Expenditures	$0.00	$1.558K
Free Cash Flow	-$29.24K	-$29.69K	-$133.5K
YoY Change		-77.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2023Q4	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q4	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	dei	Document Type DocumentType	10-Q
CY2023Q4	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q4	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023Q4	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q4	dei	Entity File Number EntityFileNumber	000-55789
CY2023Q4	dei	Entity Registrant Name EntityRegistrantName	BANTEC, INC.
CY2023Q4	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q4	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	30-0967943
CY2023Q4	dei	City Area Code CityAreaCode	(203)
CY2023Q4	dei	Local Phone Number LocalPhoneNumber	220-2296
CY2023Q4	dei	Entity Address Address Line1 EntityAddressAddressLine1	195 Paterson Ave
CY2023Q4	dei	Entity Address City Or Town EntityAddressCityOrTown	Little Falls
CY2023Q4	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2023Q4	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07424
CY2023Q4	dei	Security12b Title Security12bTitle	None
CY2023Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2023Q4	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q4	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q4	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q4	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q4	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10276063	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	101232	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35443	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	291408	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	138609	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	132762	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	178056	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	525402	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	367108	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2885	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1542	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	116973	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	127276	usd
CY2023Q4	us-gaap	Assets Assets	645260	usd
CY2023Q3	us-gaap	Assets Assets	495926	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2337385	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2215246	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3833588	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3530406	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	452820	usd
CY2023Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	386180	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	47500	usd
CY2023Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	35000	usd
CY2023Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	834000	usd
CY2023Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	834000	usd
CY2023Q4	bant	Notes And Loan Payable Current NotesAndLoanPayableCurrent	923840	usd
CY2023Q3	bant	Notes And Loan Payable Current NotesAndLoanPayableCurrent	863852	usd
CY2023Q4	bant	Mandatorily Redeemable Preferred Stock Series MandatorilyRedeemablePreferredStockSeries	343147	usd
CY2023Q3	bant	Mandatorily Redeemable Preferred Stock Series MandatorilyRedeemablePreferredStockSeries	340572	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	43630	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	41946	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8948180	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	8352264	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	74307	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	85880	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	8744201	usd
CY2023Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	8700254	usd
CY2023Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	150000	usd
CY2023Q3	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	150000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	8968508	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	8936134	usd
CY2023Q4	us-gaap	Liabilities Liabilities	17916688	usd
CY2023Q3	us-gaap	Liabilities Liabilities	17288398	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	481530	usd
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	463962	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10239681	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10239681	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9306954	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9306954	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1023	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	930	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	20577919	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	20598156	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38331900	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37855520	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-17752958	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-17256434	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	645260	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	495926	usd
CY2023Q4	us-gaap	Revenues Revenues	955734	usd
CY2022Q4	us-gaap	Revenues Revenues	606166	usd
CY2023Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	808187	usd
CY2022Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	511216	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	147547	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	94950	usd
CY2023Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	454785	usd
CY2022Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	514290	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	454785	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	514290	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-307238	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-419340	usd
CY2023Q4	us-gaap	Financing Interest Expense FinancingInterestExpense	169142	usd
CY2022Q4	us-gaap	Financing Interest Expense FinancingInterestExpense	362335	usd
CY2023Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-169142	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-362335	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-476380	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-781675	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-476380	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-781675	usd
CY2023Q4	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	25274	usd
CY2022Q4	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	36960	usd
CY2023Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-501654	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-818635	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9542698	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5327269	shares
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-16578533	usd
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	99333	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	102597	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	36960	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-781675	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-17195238	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-17256434	usd
CY2023Q4	bant	Dividends Preferred Stock One DividendsPreferredStockOne	-25274	usd
CY2023Q4	bant	Fractional Shares Issued From Reverse Split FractionalSharesIssuedFromReverseSplit	5130	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-476380	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-17752958	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-476380	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-781675	usd
CY2023Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	34197	usd
CY2022Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	91009	usd
CY2023Q4	us-gaap	Accretion Expense AccretionExpense	24110	usd
CY2022Q4	us-gaap	Accretion Expense AccretionExpense	57000	usd
CY2023Q4	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	2011	usd
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation	215	usd
CY2022Q4	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	9885	usd
CY2023Q4	bant	Gain Loss On Fee Notes Issued GainLossOnFeeNotesIssued	6000	usd
CY2022Q4	bant	Gain Loss On Fee Notes Issued GainLossOnFeeNotesIssued	57000	usd
CY2023Q4	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-414	usd
CY2022Q4	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	340	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	150788	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-303409	usd
CY2023Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-45293	usd
CY2022Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-545	usd
CY2023Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-15000	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	475815	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	144664	usd
CY2022Q4	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	-15000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28135	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-133503	usd
CY2023Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1558	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1558	usd
CY2022Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	99333	usd
CY2023Q4	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	12500	usd
CY2023Q4	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	172000	usd
CY2023Q4	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	151226	usd
CY2022Q4	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	40741	usd
CY2023Q4	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	35000	usd
CY2023Q4	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	34783	usd
CY2022Q4	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	24000	usd
CY2023Q4	bant	Purchase Of Convertible Note By Related Party PurchaseOfConvertibleNoteByRelatedParty	7575	usd
CY2022Q4	bant	Purchase Of Convertible Note By Related Party PurchaseOfConvertibleNoteByRelatedParty	37537	usd
CY2022Q4	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	3000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	95482	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	42055	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	65789	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-91448	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35443	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	186386	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	101232	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94938	usd
CY2023Q4	us-gaap	Interest Paid InterestPaid	3798	usd
CY2022Q4	us-gaap	Interest Paid InterestPaid	16164	usd
CY2022Q4	bant	Issuance Of Common Stock For Conversion Of Convertible Notes And Accrued Interest IssuanceOfCommonStockForConversionOfConvertibleNotesAndAccruedInterest	47712	usd
CY2023Q4	bant	Value Of Series C Preferred Stock In Connection With An Exchange Agreement ValueOfSeriesCPreferredStockInConnectionWithAnExchangeAgreement	5130	usd
CY2022Q4	bant	Transfer Of Debt Premium Upon Purchase By Related Party TransferOfDebtPremiumUponPurchaseByRelatedParty	45000	usd
CY2023Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	54400	usd
CY2023Q4	us-gaap	Stock Issued1 StockIssued1	25274	usd
CY2023Q4	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 - <span style="font-variant: small-caps"><span style="text-decoration:underline">NATURE OF OPERATIONS</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bantec, Inc. is a company providing products and services (“Bantec” or the “Company”), targeting the U.S. Government, state governments, municipalities, hospitals, universities, manufacturers and other building owners. Bantec provides product procurement, distribution, and logistics services through its wholly-owned subsidiary, Howco Distributing Co. (“Howco”) to the U.S. Department of Defense and Defense Logistics Agency. The Company established Bantec Sanitizing, LLC in fiscal 2021, which offers sanitizing products and equipment through its online store – bantec.store. The Company has operations based in Sparta, New Jersey and Vancouver, Washington. Howco operates in Vancouver, Washington and all other operations are in Sparta, New Jersey. The Company continues to seek strategic acquisitions and partnerships that would offer it an opportunity to grow sales and profit.</span></p>
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-476380	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28135	usd
CY2023Q4	bant	Working Capital Deficit WorkingCapitalDeficit	8422778	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-17752958	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38331900	usd
CY2023Q4	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the allowance for bad debt on accounts receivable, reserves on inventory, valuation of intangible assets for impairment analysis, valuation of the lease liability and related right-of-use asset, valuation of stock-based compensation, valuation of redeemable preferred stock, valuation of derivative liabilities, and the valuation allowance on deferred tax assets.</span></p>
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	27472	usd
CY2023Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	29472	usd
CY2023Q4	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P3Y
CY2023	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	215	usd
CY2022	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	0	usd
CY2023Q4	us-gaap	Related Parties Amount In Cost Of Sales RelatedPartiesAmountInCostOfSales	10763	usd
CY2022Q4	us-gaap	Related Parties Amount In Cost Of Sales RelatedPartiesAmountInCostOfSales	12920	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	140561	usd
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	16	shares
CY2022Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	16	shares
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	2240000	shares
CY2022Q4	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	2240000	shares
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	321020000	shares
CY2022Q4	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	6720000	shares
CY2023Q4	bant	Incremental Common Shares Attributable To Sharebased Payment Arrangements Senior Convertible Debt IncrementalCommonSharesAttributableToSharebasedPaymentArrangementsSeniorConvertibleDebt	176172911	shares
CY2022Q4	bant	Incremental Common Shares Attributable To Sharebased Payment Arrangements Senior Convertible Debt IncrementalCommonSharesAttributableToSharebasedPaymentArrangementsSeniorConvertibleDebt	208587952	shares
CY2023Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	499432927	shares
CY2022Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	217547968	shares
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	pure
CY2023Q4	us-gaap	Segment Reporting Description Of All Other Segments SegmentReportingDescriptionOfAllOtherSegments	Howco generated 100% of the consolidated sales which are primarily from department of defense. Bantec Sanitizing Inc. had no contribution to consolidated sales of its sanitizing products for the three months ended December 31, 2023.
CY2023Q4	bant	Percentage Of Tangible Assets PercentageOfTangibleAssets	0.99	pure
CY2023Q4	bant	Tangible Assets Percentage TangibleAssetsPercentage	0.01	pure
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	318880	usd
CY2023Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	168081	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	27472	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	29472	usd
CY2023Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	291408	usd
CY2023Q3	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	138609	usd
CY2023Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2011	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	132762	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	178056	usd
CY2023Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	47500	usd
CY2023Q3	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	35000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	2500	usd
CY2023Q4	bant	Debt Instrument Interest Rates During Period DebtInstrumentInterestRatesDuringPeriod	0.055	pure
CY2023Q4	bant	Debt Instrument Default Interest Rate DebtInstrumentDefaultInterestRate	0.08	pure
CY2023Q4	us-gaap	Notes Payable NotesPayable	8876471	usd
CY2023Q3	us-gaap	Notes Payable NotesPayable	8805316	usd
CY2023Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	132270	usd
CY2023Q3	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	105062	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	8744201	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	8700254	usd
CY2023Q4	us-gaap	Securities Borrowed Allowance For Credit Loss SecuritiesBorrowedAllowanceForCreditLoss	34783	usd
CY2023Q4	us-gaap	Debt Instrument Repaid Principal DebtInstrumentRepaidPrincipal	7575	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	1363100	usd
CY2023Q3	bant	Accrued Interests AccruedInterests	8700254	usd
CY2023Q4	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	1530	usd
CY2022Q4	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	0	usd
	us-gaap	Investment Company Debt Instrument Amount Repaid To Principal Excess Less InvestmentCompanyDebtInstrumentAmountRepaidToPrincipalExcessLess	298341	usd
CY2023Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	8676957	usd
CY2023	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	1363100	usd
CY2023Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	4000	usd
CY2023Q2	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.10	pure
	bant	Convertible Discount Percentage ConvertibleDiscountPercentage	0.50	pure
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	6000	usd
CY2023Q4	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.10	pure
	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	44000	usd
CY2018Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	90000	usd
CY2018Q4	bant	Vendor Settlement VendorSettlement	161700	usd
CY2023Q4	us-gaap	Debt Conversion Description DebtConversionDescription	The note bears interest at 5%, matured on June 30, 2019 and is convertible into the Company’s common stock at 50% of the lowest closing bid price during the 20 trading days immediately preceding the notice of conversion.
CY2023Q4	bant	Debt Premium Charge To Interest Expense DebtPremiumChargeToInterestExpense	90000	usd
CY2023Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	90000	usd
CY2023Q3	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	90000	usd
CY2023Q4	us-gaap	Debt Securities Held To Maturity Accrued Interest Writeoff DebtSecuritiesHeldToMaturityAccruedInterestWriteoff	49229	usd
CY2023	us-gaap	Debt Securities Held To Maturity Accrued Interest Writeoff DebtSecuritiesHeldToMaturityAccruedInterestWriteoff	46961	usd
CY2023Q3	bant	Conversion Price Percentage ConversionPricePercentage	0.65	pure
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5000	usd
CY2023Q4	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	1149211	usd
CY2023Q3	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	1077013	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	75371	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	63161	usd
CY2023Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	1073840	usd
CY2023Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	1013852	usd
CY2023Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	923840	usd
CY2023Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	863852	usd
CY2023Q4	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	150000	usd
CY2023Q3	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	150000	usd
CY2023Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	32667	usd
CY2022Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	91009	usd
CY2023Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	4386	usd
CY2023Q4	us-gaap	Accounts Receivable Noncurrent Accrued Interest Writeoff AccountsReceivableNoncurrentAccruedInterestWriteoff	150000	usd
CY2023	us-gaap	Accounts Receivable Noncurrent Accrued Interest Writeoff AccountsReceivableNoncurrentAccruedInterestWriteoff	150000	usd
CY2021Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	17500	usd
CY2021	bant	Service Vendor Fee ServiceVendorFee	2500	usd
CY2023Q4	bant	Service Arrangement ServiceArrangement	17500	usd
CY2023	bant	Service Arrangement ServiceArrangement	17500	usd
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	183259	usd
CY2023Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	183259	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	44845	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	224000	usd
CY2023Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	224000	usd
CY2023Q2	us-gaap	Other Receivables OtherReceivables	125000	usd
CY2023Q2	us-gaap	Payments For Fees PaymentsForFees	6750	usd
CY2023Q2	bant	Net Payment NetPayment	118250	usd
CY2023Q2	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	3255.21	usd
CY2023Q2	us-gaap	Repayments Of Debt RepaymentsOfDebt	156250	usd
CY2023Q2	us-gaap	Interest Expense Other InterestExpenseOther	31250	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	38000	usd
CY2023Q3	us-gaap	Other Receivables OtherReceivables	75000	usd
CY2023Q3	us-gaap	Payments For Fees PaymentsForFees	3500	usd
CY2023Q3	bant	Net Payment NetPayment	71500	usd
CY2023Q3	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1953	usd
CY2023Q3	us-gaap	Repayments Of Debt RepaymentsOfDebt	93750	usd
CY2023Q3	us-gaap	Interest Expense Other InterestExpenseOther	18750	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	22250	usd
CY2023Q4	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	136000	usd
CY2023Q4	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	100000	usd
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	3400	usd
CY2023Q4	us-gaap	Amount Of Regulatory Assistance Received1 AmountOfRegulatoryAssistanceReceived1	96875	usd
CY2023Q4	us-gaap	Clearance Fees ClearanceFees	3000	usd
CY2023Q4	us-gaap	Loan Processing Fee LoanProcessingFee	125	usd
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	90400	usd
CY2023Q4	bant	Notes Due And Payable Percentage NotesDueAndPayablePercentage	1.50	pure
CY2023Q4	bant	Variable Conversion Price Percentage VariableConversionPricePercentage	0.61	pure
CY2023Q4	bant	Investment Company Payment By Affiliate Percentage InvestmentCompanyPaymentByAffiliatePercentage	0.0499	pure
CY2023Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	20611	usd
CY2023	us-gaap	Payments For Loans PaymentsForLoans	72921	usd
CY2023Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	11588	usd
CY2023Q4	us-gaap	Repayments Of Debt RepaymentsOfDebt	20611	usd
CY2024Q1	us-gaap	Other Expenses OtherExpenses	5000	usd
CY2023Q3	us-gaap	Stock Issued1 StockIssued1	15000	usd
CY2023Q3	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.10	pure
CY2023Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	183259	usd
CY2023Q3	us-gaap	Demand Deposit Accounts DemandDepositAccounts	224000	usd
CY2023Q4	us-gaap	Preferred Stock Convertible Conversion Price Increase PreferredStockConvertibleConversionPriceIncrease	0.2
CY2023Q4	bant	Debt Instrument Convertible Conversion Price DebtInstrumentConvertibleConversionPrice	0.50	pure
CY2023Q4	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.50	pure
CY2022Q3	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	101368	usd
CY2022Q3	us-gaap	Additional Collateral Aggregate Fair Value AdditionalCollateralAggregateFairValue	461440	usd
CY2022Q3	bant	Additional Paid In Capital Including Dividends AdditionalPaidInCapitalIncludingDividends	360072	usd
CY2022Q3	us-gaap	Investment Income Dividend InvestmentIncomeDividend	13440	usd
CY2023Q4	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.22	pure
CY2023Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	224000	shares
CY2023Q3	bant	Accrued Dividends accruedDividends	3640	usd
CY2023Q4	bant	Accrued Dividends accruedDividends	855	usd
CY2023Q3	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	463962	usd
CY2023Q3	us-gaap	Dividends Stock DividendsStock	151211	usd
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	321020000	shares
CY2023Q4	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	22699	usd
CY2023Q4	bant	Preferred Stock Dividend Percentage PreferredStockDividendPercentage	0.03	pure
CY2023Q4	bant	Mandatorily Redeemable Preferred Stock Series MandatorilyRedeemablePreferredStockSeries	343147	usd
CY2023Q3	bant	Mandatorily Redeemable Preferred Stock Series MandatorilyRedeemablePreferredStockSeries	340572	usd
CY2023Q4	us-gaap	Preferred Stock Capital Shares Reserved For Future Issuance PreferredStockCapitalSharesReservedForFutureIssuance	2999750	shares
CY2023Q4	bant	Common Stock Dividend CommonStockDividend	0.99
CY2023Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	10239681	shares
CY2023Q3	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	9306954	shares
CY2023Q4	bant	Shares Available Under Plan SharesAvailableUnderPlan	100	shares
CY2023Q4	us-gaap	Shares Issued SharesIssued	20000	shares
CY2016Q4	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	370000	usd
CY2016Q4	us-gaap	Loss On Contract Termination LossOnContractTermination	2500000	usd
CY2019Q3	us-gaap	Salaries And Wages SalariesAndWages	624000	usd
CY2023Q4	us-gaap	Other Ownership Interests Value OtherOwnershipInterestsValue	3000	usd
CY2019Q2	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Provisions ValuationAllowanceForImpairmentOfRecognizedServicingAssetsProvisions	218637	usd
CY2023Q2	us-gaap	Liabilities Average Amount Outstanding LiabilitiesAverageAmountOutstanding	219613	usd
CY2023Q4	us-gaap	Other Notes Payable OtherNotesPayable	110000	usd
CY2023Q4	us-gaap	Cash Cash	25000	usd
CY2023Q4	us-gaap	Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage	0.03	pure
CY2023Q4	us-gaap	Loss Contingency Accrual Product Liability Due In Rolling Year Three LossContingencyAccrualProductLiabilityDueInRollingYearThree	2472	usd
CY2020Q4	us-gaap	Payments For Fees PaymentsForFees	276430	usd
CY2020Q4	us-gaap	Deferred Discounts Finance Charges And Interest Included In Receivables DeferredDiscountsFinanceChargesAndInterestIncludedInReceivables	40212	usd
CY2023Q2	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	16500	usd
CY2023Q2	us-gaap	Initial Franchise Fees InitialFranchiseFees	2000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Next Rolling Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextRollingTwelveMonths	4542	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Rolling Year Two LessorOperatingLeasePaymentsToBeReceivedRollingYearTwo	4679	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Rolling Year Three LessorOperatingLeasePaymentsToBeReceivedRollingYearThree	4819	usd
CY2023Q2	us-gaap	Payments For Rent PaymentsForRent	1481	usd
CY2023Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	140	usd
CY2023Q4	us-gaap	Lessee Finance Lease Discount Rate LesseeFinanceLeaseDiscountRate	0.12	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	41424	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	56701	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	38548	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	136673	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y5M1D
CY2019Q4	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	500	usd
CY2020Q2	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	79	usd
CY2023Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	18719	usd
CY2022Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	19562	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	bant	Concentrations Of Foreign Sales ConcentrationsOfForeignSales	0	usd
CY2022Q4	bant	Concentrations Of Foreign Sales ConcentrationsOfForeignSales	0	usd
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent		usd
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5327269	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9542698	shares
CY2022Q4	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt		usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets		usd
CY2023Q4	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent		usd
CY2022Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022Q4	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
CY2022Q4	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2022Q4	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2023Q4	bant	Issuance Of Common Stock For Conversion Of Convertible Notes And Accrued Interest IssuanceOfCommonStockForConversionOfConvertibleNotesAndAccruedInterest		usd
CY2022Q4	bant	Value Of Series C Preferred Stock In Connection With An Exchange Agreement ValueOfSeriesCPreferredStockInConnectionWithAnExchangeAgreement		usd
CY2023Q4	bant	Transfer Of Debt Premium Upon Purchase By Related Party TransferOfDebtPremiumUponPurchaseByRelatedParty		usd
CY2022Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts		usd
CY2022Q4	us-gaap	Stock Issued1 StockIssued1		usd
CY2022Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2023Q4	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2023Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	dei	Entity Central Index Key EntityCentralIndexKey	0001704795

Files In Submission

Name	View Source	Status
0001213900-24-022084-index-headers.html	Edgar Link	pending
0001213900-24-022084-index.html	Edgar Link	pending
0001213900-24-022084.txt	Edgar Link	pending
0001213900-24-022084-xbrl.zip	Edgar Link	pending
bant-20231231.xsd	Edgar Link	pending
ea0201405-10q_bantec.htm	Edgar Link	pending
ea020140501ex31-1_bantec.htm	Edgar Link	pending
ea020140501ex31-2_bantec.htm	Edgar Link	pending
ea020140501ex32-1_bantec.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
bant-20231231_cal.xml	Edgar Link	unprocessable
bant-20231231_def.xml	Edgar Link	unprocessable
bant-20231231_lab.xml	Edgar Link	unprocessable
bant-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0201405-10q_bantec_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BANT
Bantec, Inc. Stock $bant

2024 Q1 Form 10-Q Financial Statement

#000121390024022084 Filed on March 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BANT Bantec, Inc. Stock $bant

2024 Q1 Form 10-Q Financial Statement

#000121390024022084 Filed on March 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BANT
Bantec, Inc. Stock $bant